Clinical trials
Phase 1/2 Diabetes Mellitus, Type 2 trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2006 | 1 |
| 2008 | 1 |
| 2011 | 5 |
| 2013 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 2 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Unknown status | 7 |
| Recruiting | 2 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fuzhou General Hospital | 2 |
| Shandong University | 2 |
| Beijing QL Biopharmaceutical Co.,Ltd | 1 |
| Diabetes Care Center of Nanjing Military Command | 1 |
| Gan and Lee Pharmaceuticals, USA | 1 |
| Guang'anmen Hospital of China Academy of Chinese Medical Sciences | 1 |
| Innovent Biologics (Suzhou) Co. Ltd. | 1 |
| Peking University Aerospace Center Hospital | 1 |
| Peking University First Hospital | 1 |
| Second Affiliated Hospital of Guangzhou Medical University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 19 |
| Diabetes Mellitus | 4 |
| Insulin Resistance | 2 |
| Autoimmune Diseases | 1 |
| Diabetes Mellitus, Type 1 | 1 |
| Dyslipidemias | 1 |
| Inflammation | 1 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.